Available via license: CC BY 4.0
Content may be subject to copyright.
Citation: Xu, V.W.; Nizami, M.Z.I.;
Yin, I.X.; Yu, O.Y.; Lung, C.Y.K.; Chu,
C.H. Application of Copper
Nanoparticles in Dentistry.
Nanomaterials 2022,12, 805.
https://doi.org/10.3390/
nano12050805
Academic Editors: Krasimir Vasilev
and Takuya Kitaoka
Received: 28 January 2022
Accepted: 25 February 2022
Published: 27 February 2022
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2022 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
nanomaterials
Review
Application of Copper Nanoparticles in Dentistry
Veena Wenqing Xu , Mohammed Zahedul Islam Nizami * , Iris Xiaoxue Yin, Ollie Yiru Yu ,
Christie Ying Kei Lung and Chun Hung Chu
Faculty of Dentistry, University of Hong Kong, Hong Kong 999077, China; u3008489@connect.hku.hk (V.W.X.);
irisxyin@hku.hk (I.X.Y.); ollieyu@hku.hk (O.Y.Y.); yklung@graduate.hku.hk (C.Y.K.L.); chchu@hku.hk (C.H.C.)
*Correspondence: nizami01@hku.hk
Abstract:
Nanoparticles based on metal and metallic oxides have become a novel trend for dental
applications. Metal nanoparticles are commonly used in dentistry for their exclusive shape-dependent
properties, including their variable nano-sizes and forms, unique distribution, and large surface-area-
to-volume ratio. These properties enhance the bio-physio-chemical functionalization, antimicrobial
activity, and biocompatibility of the nanoparticles. Copper is an earth-abundant inexpensive metal,
and its nanoparticle synthesis is cost effective. Copper nanoparticles readily intermix and bind with
other metals, ceramics, and polymers, and they exhibit physiochemical stability in the compounds.
Hence, copper nanoparticles are among the commonly used metal nanoparticles in dentistry. Copper
nanoparticles have been used to enhance the physical and chemical properties of various dental
materials, such as dental amalgam, restorative cements, adhesives, resins, endodontic-irrigation
solutions, obturation materials, dental implants, and orthodontic archwires and brackets. The
objective of this review is to provide an overview of copper nanoparticles and their applications
in dentistry.
Keywords: copper nanoparticles; antimicrobial; dentistry
1. Introduction
Copper is a popular element in medical and dental research due to its antimicrobial
properties and low toxicity [
1
,
2
]. The antimicrobial activities are induced by either copper’s
metal ions or the oxidized cupric ions derived from copper nanoparticles (1–100 nm).
Moreover, copper is readily available for the synthesis of copper nanoparticles, so it is
cost effective [
3
]. Copper nanoparticles can be processed either naturally or via chemical
synthesis [
4
–
7
]. In addition, they can easily oxidize in air or water and produce copper oxide
nanoparticles. Like most metal nanoparticles that are commonly used in dentistry, copper
particles have variable nano-sizes and forms, a unique distribution, and a large surface-
area-to-volume ratio. These properties enhance the bio-physio-chemical functionalization,
antimicrobial activity, and biocompatibility of the nanoparticles. Reports have shown
that copper oxide nanoparticles are antimicrobial and inhibit biofilm formation [
8
,
9
]. The
high surface-area-to-volume ratio of copper nanoparticles enhances their antimicrobial
ability [
10
]. These nanoparticles’ antibacterial activities have been widely investigated,
although the exact mechanism of copper nanoparticles against microbes is not
clear [11–13]
.
Copper nanoparticles have demonstrated higher bactericidal activity against E. coli, B.
subtilis, and S. aureus compared with silver nanoparticles, which are one of the nanoparticles
commonly used nanoparticles in biomedical research [14,15].
Researchers want to develop dental materials that have antimicrobial properties to
prevent oral infection. Copper nanoparticles exhibit antimicrobial activities and other
metallic properties associated with dental applications. Preparing these nanoparticle
composites with existing dental materials is easy and is said to be physiochemically stable.
Still, they have a very limited clinical application. In dentistry, copper nanoparticles
have mostly been studied as a modifier in amalgam and antimicrobial agents. Recently,
Nanomaterials 2022,12, 805. https://doi.org/10.3390/nano12050805 https://www.mdpi.com/journal/nanomaterials
Nanomaterials 2022,12, 805 2 of 15
several dental materials were studied with regard to copper nanoparticles, and it was
reported that copper nanoparticles can be added to dental cements, restorative materials,
adhesives, resins, irrigating solutions, obturations, orthodontic archwires and brackets,
implant surface coatings, and the bone regeneration process [
15
–
20
]. The results were
impressive but a bit ambiguous for clinical applications.
A search in PubMed using ((copper nanoparticles) AND (dentistry OR dental)) found
no relevant review articles. The aim of this review is to highlight the research directions,
their outcomes, and the feasibility of future studies. Therefore, we performed a systematic
search of the publications in English and included the maximum number of works in the
literature. We searched three common databases, namely, EMBASE, Google Scholar, and
MEDLINE. In the search, the keywords were (copper OR (copper nanoparticles) OR (copper
nanocomposite)) AND (dentistry OR (dental material)). These keywords covered as much
information about copper nanoparticles in dentistry as possible without overlooking related
research. This review includes all publications on the application of copper nanoparticles
in dentistry. Abstracts, editorials, and letters to the editor were excluded. Among the
vast number of articles reviewed, we have summarized the dental materials with copper
nanoparticles into four main categories. They are metals and alloys, polymers and resins,
restorative cements, and miscellaneous dental materials.
2. Antibacterial Mechanism of Copper Nanoparticles
Copper is a well-established antimicrobial and anti-inflammatory agent with a long
history of medicinal applications [
21
,
22
]. The nano-sized particles and high surface-area-to-
volume ratio allow copper nanoparticles to exhibit broad-spectrum antibacterial and antivi-
ral activities [
12
]. Copper nanoparticles may have a similar mode of action as other metal
nanoparticles. Although several studies have shown that copper-nanoparticle-containing
materials demonstrate antibacterial activity and biocompatibility, related antibacterial
mechanisms are not inclusive [
23
]. A few studies were conducted in an attempt to ex-
plore the antibacterial mechanism of copper nanoparticles. Mainly, three hypothetical
mechanisms were commonly described. First, copper nanoparticles accumulate in the
bacterial membrane and change its permeability. They then remove membrane proteins,
lipopolysaccharides, and intracellular biomolecules and cause the dissipation of the proton-
motive energy around the plasma membrane [
24
–
26
]. Second, reactive oxygen species
from nanoparticles (in the form of nanoparticles or ions) process post-oxidative dam-
age in cellular structures [
27
–
30
]. Third, cells’ uptake of ions (generated via nanoparti-
cles) decreases intracellular adenosine triphosphate production and deoxyribonucleic acid
(DNA) replication [31–34].
Studies demonstrated that the carboxyl group of bacterial lipoproteins has a negative
charge that attracts positive copper ions. After binding with copper ions, bacterial cell
membranes and their permeability change, and copper ions enter the cells. When they
merge with phosphorus- and sulfur-containing biomolecules (i.e., DNA), the copper ions
alter the cell structures and cell proteins. This alteration inhibits the cell’s biochemical
processes and causes cell death [
35
,
36
]. However, copper ions inhibit enzymatic activity.
They alter DNA or protein synthesis, inactivate their enzymes, and promote hydrogen
peroxide production [
37
]. In addition, nanoparticles denature protein molecules by inter-
acting with their sulfhydryl group [
37
]. At the same time, DNA, ribonucleic acid, proteins,
and cytoplasm leak out through the permeable membrane, causing cell damage that kills
bacteria [38]
. Furthermore, several other hypotheses of possible modes of copper nanopar-
ticle and bacterial interaction exist, such as the permeabilization of the plasma membrane,
the peroxidation of membrane lipids, changes in proteins, the inhibition of protein assem-
bly and activity, and the deformation of nucleic acids [
39
]. In most cases, all of these are
directed in the same way. We believe that further
in vitro
and
in vivo
studies should be
conducted to produce a systematic outline [40].
Many studies investigated copper nanoparticles’ antibacterial activities. However, few
studies reported their antiviral action. They demonstrated that copper nanoparticles target
Nanomaterials 2022,12, 805 3 of 15
the viral genome, especially encoding the genes responsible for viral infections [
21
,
41
].
In addition, some studies showed a similar reactive oxygen species process in the viral
envelope or capsid, which resembles antibacterial activity [
21
]. Viruses are more vulnerable
to injuries induced by copper nanoparticles because, unlike bacteria and fungi, they do
not have a repair mechanism. This leads to instant cell death [
39
]. Processes that cause
the immediate inactivation of microbes upon contact are known as “contact killing” [
42
].
In many studies, researchers have taken advantage of this “contact killing” property and
have created copper-nanoparticle-functionalized antiviral surfaces. Copper nanoparticles
are co-integrated into surface research to increase “contact killing”, as well as to develop
antibacterial and antiviral combination effects [
43
]. Figure 1demonstrates the mechanism
of copper nanoparticles’ antibacterial activities in bacterial cells.
Nanomaterials 2022, 12, x FOR PEER REVIEW 3 of 14
Many studies investigated copper nanoparticles’ antibacterial activities. However,
few studies reported their antiviral action. They demonstrated that copper nanoparticles
target the viral genome, especially encoding the genes responsible for viral infections
[21,41]. In addition, some studies showed a similar reactive oxygen species process in the
viral envelope or capsid, which resembles antibacterial activity [21]. Viruses are more vul-
nerable to injuries induced by copper nanoparticles because, unlike bacteria and fungi,
they do not have a repair mechanism. This leads to instant cell death [39]. Processes that
cause the immediate inactivation of microbes upon contact are known as “contact killing”
[42]. In many studies, researchers have taken advantage of this “contact killing” property
and have created copper-nanoparticle-functionalized antiviral surfaces. Copper nanopar-
ticles are co-integrated into surface research to increase “contact killing”, as well as to
develop antibacterial and antiviral combination effects [43]. Figure 1 demonstrates the
mechanism of copper nanoparticles’ antibacterial activities in bacterial cells.
Figure 1. Antibacterial mechanism of copper nanoparticles.
1. Attach to the cell wall and release copper ions.
2. Adhere to the cell membrane and enter the cell.
3. Disrupt the cell wall and membrane, denature protein, interrupt enzymatic activity, interrupt
deoxyribonucleic acid (DNA) replication, and interrupt adenosine triphosphate (ATP) produc-
tion.
4. Generate reactive oxygen species. Reactive oxygen species further interrupt DNA replication and
initiate the breakdown of DNA, denature ribosomes, and denature protein.
3. Copper Nanoparticles in Dental Materials
Copper nanoparticles present antimicrobial and bio-physio-chemical properties.
They enrich the material pool to minimize the shortage of dental materials in various clin-
ical applications. Generally, copper nanoparticles are used in dental metals and alloys,
dental polymers and resins, dental cements, and miscellaneous dental materials (Table 1).
Figure 1. Antibacterial mechanism of copper nanoparticles.
1. Attach to the cell wall and release copper ions.
2. Adhere to the cell membrane and enter the cell.
3.
Disrupt the cell wall and membrane, denature protein, interrupt enzymatic activity,
interrupt deoxyribonucleic acid (DNA) replication, and interrupt adenosine triphos-
phate (ATP) production.
4.
Generate reactive oxygen species. Reactive oxygen species further interrupt DNA
replication and initiate the breakdown of DNA, denature ribosomes, and
denature protein
.
3. Copper Nanoparticles in Dental Materials
Copper nanoparticles present antimicrobial and bio-physio-chemical properties. They
enrich the material pool to minimize the shortage of dental materials in various clinical
applications. Generally, copper nanoparticles are used in dental metals and alloys, dental
polymers and resins, dental cements, and miscellaneous dental materials (Table 1).
Nanomaterials 2022,12, 805 4 of 15
Table 1. Properties, applications, and functions of dental materials with copper nanoparticles.
Materials [Reference(s)] Properties Applications Functions
Dental metals and alloys
Copper-coated metal [44,45] Offer antimicrobial properties Denture framework Prevent stomatitis
Copper amalgam alloy [46–49]Improve microstructural
Improve mechanical properties Amalgam restoration Prevent corrosion
Copper-linked alloy [50–56] Offer antimicrobial properties Dental implant Prevent implantitis
Magnesium–copper alloy [57,58] Offer antimicrobial properties Dental implant Prevent implantitis
Titanium–copper alloy [57–71] Offer antimicrobial properties Dental implant Prevent implantitis
Titanium–hydroxyapatite–copper
alloy [72]Offer antimicrobial properties Dental Implant Prevent implantitis
Nickel–titanium–copper alloy
[73–79]
Enhance mechanical properties
Enhance thermal properties
Prevent galvanic corrosion
Reduce alloy aging
Orthodontic bracket
Orthodontic archwire
Facilitate orthodontic
tooth movement
Dental polymers and resins
Copper-nanoparticle-incorporated
acrylic resin [80]Offer antimicrobial properties Denture soft liner Prevent stomatitis
Copper-doped mesoporous
bioactive glass nanosphere acrylic
resin [81]
Facilitate copper-ion release
Offer antimicrobial properties Denture acrylic base Prevent stomatitis
Copper nanoparticles with
adhesive resin [82]Offer antimicrobial properties Dental adhesive Prevent secondary caries
Polyacrylic acid–copper iodide
nanoparticles with adhesive resin [83]Offer antimicrobial properties Dental adhesive Prevent secondary caries
Dental Cements
Copper [84–86] Offer antimicrobial properties Lining materials Prevent secondary caries
Copper(I)-catalysed azide-alkyne
cycloaddition composites [87]Reduce shrinkage stress Composite resin
restoration Prevent secondary caries
Copper nanoparticles incorporated in
glass ionomer cement [88]Offer antimicrobial properties Glass ionomer
restoration Prevent secondary caries
Copper ions releasing blue calcium
phosphate cement [89]
Offer antimicrobial properties
Improve cytocompatibility
Regenerative dental
material Promote bone formation
Functionalized copper phosphate
nanoparticles [90,91]
Increase vascularization
Enhance bone regeneration
Regenerative dental
material Promote bone formation
Copper-modified zinc oxide
phosphate [92]Reduce marginal gap Luting cement Prevent secondary caries
Miscellaneousdental materials
Copper nanoparticles [93–102]Enhance anti-inflammatory
effects Periodontal therapy Prevent inflammation
Copper-based substance [103–107] Offer antimicrobial properties Endodontic irrigation solution
Endodontic paste Prevent apical reinfection
Nano copper-nonstoichiometric
dicalcium silicate [108]
Offer antimicrobial properties
Facilitate tissue regeneration Regenerative dental material Promote bone formation
Copper-doped biphasic calcium
phosphate [109,110]
Improve bone regeneration
Act as a bone substitution Synthetic bone graft material Promote bone formation
Graphene oxide copper
nanocomposite [111]Enhance bone regeneration Regenerative dental material Promote bone formation
3.1. Copper Nanoparticles in Dental Metals and Alloys
Prosthesis-induced inflammatory diseases, such as stomatitis and peri-implantitis,
pose challenges in clinical dentistry. Several strategies have been applied to solve these
problems. However, no specific solution has yet been found. Copper nanoparticles may
play a role in controlling infections. Copper nanoparticles destroy genomic and plasmid
DNA, making them an ideal alternative to antimicrobial surface coatings [
44
]. In addi-
tion, copper nanoparticles’ “contact killing” ability may also be well considered. Copper-
Nanomaterials 2022,12, 805 5 of 15
nanoparticle-incorporated removable and fixed partial denture framework designs could
solve denture-induced stomatitis and oral infections [45].
Dental amalgam restoration occupies a unique position in dentistry. These amalgam
alloys are broadly known as low-copper (5% or less copper) and high-copper alloys (13%
to 30% copper). A study reported that through the increasing of their copper density,
conventional dental amalgam alloys improved their microstructural and mechanical prop-
erties. Reports have also revealed the disappearance of the gamma-2 phase in copper
content with more than 20 wt% [
46
]. High-copper amalgams remain the leading materials
in Europe, America, and other advanced markets. A report stated that non-gamma-2
amalgams had superior strength and corrosion resistance properties [
47
]. In addition,
high-copper amalgam alloys showed less marginal deterioration in clinical studies, result-
ing in durable restorations [
48
]. Studies revealed that through the increasing of copper
nanoparticles in amalgam, the gamma-2 phase can be eliminated to increase the amalgam’s
compressive strength [49].
Implant dentistry has always faced the problem of peri-implantitis. Microbial infection
is one of the most common postoperative complications of implant surgery to be resolved.
It is a complex situation, and, apparently, eliminating its occurrence is the only way to
overcome it. However, it is generally impossible to stop the incidence completely. The ad-
vanced biomaterial research confirmed that biofilm formation on the implant surface is the
main cause, and it leads to the serious consequences of implant-related
infections [112,113]
.
In recent decades, studies focused on developing new implant materials or applying var-
ious coatings on existing implants using nanoparticles to inhibit biofilm formation and
to prevent biofilm-related infections. Some studies involved applying antibiotic surface
coatings to metal implants to develop prolonged antimicrobial action [114,115]. However,
this process was not successful due to the unstable bond between the surface coatings
and implants, as well as the risk of antibiotic resistance due to the continuous release of
antibiotics in the body [
116
,
117
]. Many researchers have used copper nanoparticles for the
surface modification of metallic implants [118,119].
Nisshin Steel (Tokyo, Japan) made the first copper-linked antimicrobial stainless steel
for biomedical applications [
113
]. Several studies have reported using copper nanoparticles
as an antimicrobial surface coating on different types of medical-grade stainless steel, such
as 317L stainless steel [
23
,
50
–
53
,
113
], 316L stainless steel [
23
,
54
], 304 stainless steel [
55
],
and 420-copper stainless steel [
56
]. Some studies have reported using copper nanoparticles
for the development of a magnesium–copper alloy as an implant material [57,58]. Several
studies have also reported using copper nanoparticles for the surface modification of
titanium implants [
57
–
63
]. Moreover, some studies have shown that the titanium–copper
alloy exhibits antibacterial and anti-aging properties. The studies have also demonstrated
that these antimicrobial properties could be tuned via changing the copper concentration
of the alloy composition [
64
–
66
]. Another study stated that copper-containing mesoporous
bio-glass reduced bacterial activity and biofilm formation by releasing copper ions [
67
–
69
].
A study reported that copper nanoparticles coating dental implant healing caps in-
hibited bacteria and biofilm formation [
70
]. On the other hand, another report showed
that a copper-bearing titanium alloy implant exhibited anti-infective properties against
oral bacteria. They also demonstrated that a titanium–copper alloy not only inhibited
peri-implant infections but also possessed biocompatibility [
71
]. Copper-nanoparticle
hydroxyapatite is antibacterial. A study reported that a titanium–copper alloy and a
titanium-copper ion-doped hydroxyapatite inhibited oral bacteria [
72
]. A Titanium-copper
alloy reduced the formation of biofilms to prevent implant failure. It was also effective
against implantitis-associated oral bacterial species. Therefore, the study recommended
using a titanium–copper alloy as an alternative for dental implants [
61
]. These are still in
the laboratory stage, and, therefore, further clinical studies should be aimed at validating
the application of copper-nanoparticle-functionalized implants in clinical implant dentistry.
The inclusion of copper nanoparticles in a nickel–titanium alloy offers several benefits
in orthodontic appliances. Copper nanoparticles in archwire reduced loading stress and pro-
Nanomaterials 2022,12, 805 6 of 15
vided a relatively high unloading stress, which increased orthodontic tooth movement and
was explained as a lower stress hysteresis [
73
,
74
]. A study demonstrated that the addition
of copper nanoparticles to metallic orthodontic appliances developed clinical significance
in terms of hyperelasticity, conversion temperature, and load cycling behavior [
73
]. Studies
have furthermore reported that the presence of copper nanoparticles in the nickel–titanium
orthodontic archwire reduced the aging effect and galvanic corrosion [73,75].
Studies showed that copper–nickel–titanium wires improved mechanical and thermal
properties [
76
,
77
]. The addition of copper nanoparticles increased friction under both wet
and dry conditions [
78
]. Furthermore, a clinical study compared copper–nickel–titanium
archwire and nickel–titanium archwire for correcting mandibular incisor crowding and
found no impact on the correction of the crowding [
79
]. Another study found that the
benefits of the loading pattern of the copper–nickel–titanium wire obtained from the
laboratory were not reflected in the clinical settings. Therefore, further investigations were
suggested to ensure and control these wires’ clinical performance in orthodontic practice.
3.2. Copper Nanoparticles in Dental Polymers and Resins
A heat-cured thermoset denture base with copper oxide nanoparticles is effective to
inhibit the growth of C. albicans, which is mainly responsible for denture stomatitis [
120
].
Moreover, another study found that copper oxide nanoparticles released ions while they
were incorporated into different resin formulations (i.e., heat-cured acrylic resin denture,
chemically cured soft liner, and cream-type adhesive). This ion release could be controlled
and utilized in therapeutic drug delivery for the treatment of oral diseases. However, the re-
lease of these ions may vary. A study showed that the denture base and adhesive had higher
releases compared with the denture liner [
80
]. Researchers may explore the controlled and
optimum therapeutic release of copper ions for an optimum clinical outcome. A study re-
ported copper-doped mesoporous bioactive glass nanosphere-incorporated resin exhibited
antimicrobial properties, mechanical properties, and a better aging resistance effect [
81
]. An
etch-and-rinse adhesive with copper nanoparticles appeared to have antimicrobial activity
and prevented the degradation of the adhesive interface without altering the mechanical
properties [
82
]. Polyacrylic acid-coated copper iodide nanoparticles in another study acted
as an antibacterial additive to adhesive, and their bonding strength or biocompatibility was
not affected [
83
]. Another study showed that copper nanoparticles added to an adhesive
improved the shear bond strength and antibacterial properties without cytotoxicity [121].
3.3. Copper Nanoparticles in Dental Cements
Several
in vitro
studies showed that copper cements developed compressive strength,
solubility, and antibacterial activity, and they were recommended for use as cariostatic
lining under a less soluble restorative material [
84
–
86
]. Some studies also revealed that
copper in restorative materials reduced microorganisms’ growth and viability [
122
] and
improved the bond on the teeth interface [
123
]. Moreover, fluoridated amalgam demon-
strated better caries prevention in both primary and secondary caries adjacent to the
restoration [
124
]. A study reported photo-polymerized copper(I)-catalyzed azide-alkyne
cycloaddition composites to be mechanically strong and highly tough materials. In addition,
they reduced shrinkage stress and generated a modest exothermic reaction [
87
]. Another
study showed that copper nanoparticles added to a commercial glass ionomer developed
antibacterial activity against oral strains [
88
]. On the other hand, blue calcium phosphate
cement with copper ions in another study showed a synergized dual antibacterial effect
and cytocompatibility [
89
]. Many studies have shown that calcium phosphate cement
with copper phosphate nanoparticles could promote vascularized new bone formation
around cancerous bone defects [
90
,
91
]. On the other hand, a copper-modified zinc oxide
phosphate cement showed low surface allocations of copper but no improvement in its
antimicrobial properties [
92
]. Therefore, with this limited study, it is difficult to justify the
clinical application. In light of this, the optimization of copper use in restorative materials
Nanomaterials 2022,12, 805 7 of 15
for clinical applications should be investigated further in relation to the various strains
associated with prosthesis-induced oral infection.
3.4. Copper Nanoparticles in Miscellaneous Dental Materials
Copper is the third-most abundant trace element in the human body [
125
,
126
]. Some
reports stated that the lack of copper had a negative influence on immune cells (i.e.,
neutrophils, macrophages, T cells, and natural killer cells), decreased interleukin-2 produc-
tion, and alternately enhanced proinflammatory cytokine production (e.g., tumor necrosis
factor-
α
, and matrix metalloproteinase-2 and -9), which degraded the collagen and ex-
tracellular matrix components in the periodontal ligament [
93
]. Because copper acts as
a cofactor for metalloenzyme (i.e., superoxide dismutase), which is an essential antioxi-
dant for chronic periodontitis, an optimal level of copper is essential for the prevention of
inflammatory passages [93].
Copper is essential for the development of connective tissue. The elevation of serum
copper has reflected the changes occurring in the periodontal collagen metabolism of
periodontitis patients [
94
]. A study reported an improvement in chronic periodontitis
in diabetic and non-diabetic patients using increased copper ions levels at baseline for
nonsurgical periodontal therapy [
95
]. Several studies have also reported increased copper
ion levels in patients suffering from chronic and aggressive periodontitis, as well as in acute
and chronic gingivitis [
96
–
98
]. A study reported a link between the salivary copper ion
level and periodontitis [
99
]. However, the exact mechanism of the increase in copper in the
plasma and its association with periodontal disease is still unclear and needs to be identified.
Some studies showed the therapeutic application of copper nanoparticles for periodontal
therapy. They demonstrated that copper-nanoparticle-based antimicrobial ions inhibited
bacterial growth. They also observed the controlled and sustained release of bactericidal
copper concentrations for localized periodontal therapy [
100
]. Furthermore, some studies
used copper-nanoparticle-containing composite materials for periodontal therapy. They
used a sodium copper chlorophyllin solution to reduce the production of volatile sulfur
compounds by inhibiting the periodontal anaerobes associated with malodour, and they
recommended using it to improve oral and periodontal health [101].
Another study used copper-calcium hydroxide nanoparticles for treating apical pe-
riodontitis in an endodontically treated tooth, and it recommended using them to treat
periodontitis [
102
]. Researchers have used several copper nanoparticle formulations for
periodontal therapy. However, these nanoparticle formulations are still limited in labora-
tory research, and their effects in clinical applications remain unclear. Further dedicated
research may improve the use of copper nanoparticles in antimicrobial, anti-inflammatory,
and regenerative periodontal therapy.
Endodontic treatment mostly fails due to microbial infections. The inadequate disin-
fection of root canals is a main cause of post-treatment reinfection [
127
]. Studies showed
that bacteria can survive inside the root canal after a careful chemo-mechanical prepara-
tion [
128
]. Copper nanoparticles, due to their ionic compounds, have demonstrated the
potential to produce and capture electrons, as well as to generate radical oxygen species.
These particles have led to toxic hydroxyl radical production and constitute an antimi-
crobial agent in endodontic treatment [
103
,
104
]. On the other hand, copper nanowires
have shown excellent antimicrobial effects against the oral microbes associated with the en-
dodontic systems, so it is suggested that they be considered for root canal disinfection [
105
].
Moreover, a study explained the antibacterial effect of copper sulfate nanoparticles and
proposed further clinical trials for clinical settings [
106
]. Biofilm is resistant to common
intracanal irrigation, antimicrobial drugs, and the host immune response. A study reported
that in such cases, copper hydroxide nanoparticle–based endodontic paste can reduce the
growth and replication time of root canal system–associated oral microbes, which affects the
formation and persistence of biofilm. The researchers suggested using copper hydroxide
nanoparticle–based endodontic paste for the prevention and treatment of biofilm-associated
endodontic infections [107].
Nanomaterials 2022,12, 805 8 of 15
With the progress of multifunctional biomaterials in bone grafting, the possibility
of osteogenesis and angiogenesis has attracted attention in bone and tissue regeneration
research. Inspired by the antibacterial activity of copper ions, a study reported develop-
ing a copper-nanoparticle-based nonstoichiometric dicalcium silicate for infectious bone
repair [
108
]. Another study reported that a copper-doped biphasic calcium phosphate
powder that was made of hydroxyapatite and
β
-tricalcium phosphate powder exhibited
antibacterial activity. In addition, they reported that it had good adherence to bone marrow
cells and maintained good cell viability. Therefore, they recommended it as a promising bio-
ceramic for bone substitution and/or prosthesis coatings [
109
,
110
]. A study reported using
graphene oxide copper nanocomposites for bone regeneration and revealed vascularized
new bone formation [
111
]. Although studies are limited in this field, they are promising.
Clinical studies using copper nanoparticles in various tissue engineering strategies may
result in a new direction of regenerative biomaterials.
4. Biocompatibility Studies of Copper Nanoparticles
The biocompatibility of nanoparticles is an important concern these days. The rapid
growth of nanotechnology is rampant in every research field, including biomedical research.
However, to date, no authentic information exists on the inferences of nanoparticles on
human health [
129
]. Copper is a necessary trace element, and its deficiency is conducive to
various diseases in humans. In addition, it acts as a catalyst cofactor in some redox enzymes
that are essential for broad-spectrum metabolic processes. On the other hand, if the copper
intake exceeds the tolerable limit, it shows toxic effects that lead to cell death [
130
]. Despite
the great potential of the biomedical application of copper nanoparticles, toxicity studies of
these nanoparticles are mostly confined to in vitro studies.
Copper nanoparticles have shown toxic effects on several cell lines [
131
–
137
]. Several
in vitro
studies have been conducted. However, only a few studies reported the
in vivo
toxicity of copper nanoparticles [
138
–
141
]. No information was provided on the bioavail-
ability and excretion data of long-term exposure to copper nanoparticles. Future research is
needed to provide a detailed and systematic overview of both the
in vitro
and the
in vivo
toxicity of copper nanoparticles, as well as their kinetics. Recently, the preliminary inves-
tigation of the biocompatibility of copper nanoparticles showed that they have toxicity
in both humans and the environment [
141
,
142
]. Even though copper is sustained in the
homeostasis of the human body, excess copper showed toxic effects on the kidney and
liver [
142
,
143
]. Although the possible risks of copper nanoparticles have been identified in
human health, their subacute toxicity has not yet been defined.
Copper nanoparticles that are 23.5 nm in size are considered to be class 3 medium toxic
materials, with an LD50 value of 413 mg/kg of body weight. Copper nanoparticles’ toxicity
is related to their ionization [
138
]. Copper nanoparticles lead to ultra-high reactiveness
due to their large surface and active functional ions. They react with hydrogen ions in the
gastric juice and produce a large amount of hydrogen carbonate, and their excretion leads
to kidney disorders. In addition, a study showed that the toxicity of copper nanoparticles
depends on gender. Male mice showed more severe toxic symptoms than females after
being exposed to the same mass of nanoparticles [138]. Another study also identified that
the increased production of reactive oxygen species and reactive nitrogen species plays an
important role in copper nanoparticle-induced organ impairment [144].
The interaction and impact of nanoparticles on cells and tissues have been explained
differently based on their distribution, particle size, and penetration capacity. Studies have
also reported that the variation of the effects depends on the different synthesis methods
of nanoparticles [
145
]. Therefore, with this limited study, it is difficult to bring a gross
scenario. The effect and involvement of nanoparticles should be clearly defined. Thus,
detailed studies focusing on their toxicity, bioavailability, kinetics, and biodistribution
in different organs, including the liver, brain, lung, heart, and spleen, should be further
investigated. Although, some studies described the potentials of copper and other metallic
nanoparticles in specific or different aspects of dental applications, the biosafety was not
Nanomaterials 2022,12, 805 9 of 15
clearly identified [
146
–
148
]. At the same time, the synthesis, the morphological and physic-
ochemical properties of copper nanoparticles, and these properties’ impacts also need to be
explored. Hence, concrete information regarding copper nanoparticles’ biocompatibility
will be in the frame for their future applications.
5. Conclusions
Copper nanoparticles play a dual role in the development of the properties of dental
materials. The inclusion of copper nanoparticles may improve the physio-mechanical
properties and introduce or enhance the antimicrobial activities of various dental materials.
It is expected that researchers and clinicians will focus on the perspective of cost-effective
copper nanoparticles in dentistry. This will reveal potentials and limitations, as well as
open a new door to dental biomaterials research for the use of copper nanoparticles in
clinical dental practice.
Author Contributions:
V.W.X. and M.Z.I.N. equally conceived the conceptual design, interpretation,
and writing—original draft preparation; I.X.Y. and C.Y.K.L. critically commented; and M.Z.I.N.,
O.Y.Y., and C.H.C. revised the draft. All authors have read and agreed to the published version of
the manuscript.
Funding:
This review was funded by the National Natural Science Foundation of China (NSFC)
General Program 81870812.
Conflicts of Interest: The authors declare no conflict of interest.
References
1.
Chandraleka, S.; Ramya, K.; Chandramohan, G.; Dhanasekaran, D.; Priyadharshini, A.; Panneerselvam, A. Antimicrobial
mechanism of copper (II) 1,10-phenanthroline and 2,2
0
-bipyridyl complex on bacterial and fungal pathogens. J. Saudi Chem. Soc.
2014,18, 953–962. [CrossRef]
2.
O’Gorman, J.; Humphreys, H. Application of copper to prevent and control infection. Where are we now? J. Hosp. Infect.
2012
,
81, 217–223. [CrossRef]
3.
Ingle, A.P.; Duran, N.; Rai, M. Bioactivity, mechanism of action, and cytotoxicity of copper-based nanoparticles: A review. Appl.
Microbiol. Biotechnol. 2014,98, 1001–1009. [CrossRef]
4. Khan, F.A. Biotechnology Fundamentals, 2nd ed.; CRC Press: Boca Raton, FL, USA, 2017; ISBN 9780815370048.
5. Ermini, M.L.; Voliani, V. Antimicrobial nano-agents: The copper age. ACS Nano 2021,15, 6008–6029. [CrossRef]
6.
Ramyadevi, J.; Jeyasubramanian, K.; Marikani, A.; Rajakumar, G.; Rahuman, A.A. Synthesis and antimicrobial activity of copper
nanoparticles. Mater. Lett. 2012,71, 114–116. [CrossRef]
7. Wei, Y.; Chen, S.; Kowalczyk, B.; Huda, S.; Gray, T.P.; Grzybowski, B.A. Synthesis of stable, low-dispersity copper nanoparticles
and nanorods and their antifungal and catalytic properties. J. Phys. Chem. C Nanomater. Interfaces
2010
,114, 15612–15616.
[CrossRef]
8.
Maleki Dizaj, S.; Barzegar-Jalali, M.; Zarrintan, M.H.; Adibkia, K.; Lotfipour, F. Calcium carbonate nanoparticles as cancer drug
delivery system. Expert Opin. Drug Deliv. 2015,12, 1649–1660. [CrossRef]
9.
Anu, K.; Maleeka Begum, S.; Rajesh, G.; Renuka Devi, K. Wet Biochemical Synthesis of Copper Oxide Nanoparticles Coated on
Titanium Dental Implants. Int. J. Adv. Res. Sci. Eng. Technol. 2016,3, 1191–1194.
10.
Nezhad, S.S.; Khorasgani, M.R.; Emtiazi, G.; Yaghoobi, M.M.; Shakeri, S. Isolation of copper oxide (CuO) nanoparticles resistant
Pseudomonas strains from soil and investigation on possible mechanism for resistance. World J. Microbiol. Biotechnol.
2014
,
30, 809–817. [CrossRef]
11.
Chatterjee, A.K.; Sarkar, R.K.; Chattopadhyay, A.P.; Aich, P.; Chakraborty, R.; Basu, T. A simple robust method for synthesis of
metallic copper nanoparticles of high antibacterial potency against E. coli.Nanotechnology
2012
,23, 085103. [CrossRef] [PubMed]
12.
Essa, A.M.M.; Khallaf, M.K. Antimicrobial potential of consolidation polymers loaded with biological copper nanoparticles. BMC
Microbiol. 2016,16, 144. [CrossRef]
13.
Zakharova, O.V.; Godymchuk, A.Y.; Gusev, A.A.; Gulchenko, S.I.; Vasyukova, I.A.; Kuznetsov, D.V. Considerable variation of
antibacterial activity of Cu nanoparticles suspensions depending on the storage time, dispersive medium, and particle sizes.
BioMed Res. Int. 2015,2015, 412530. [CrossRef]
14.
Ruparelia, J.P.; Chatterjee, A.K.; Duttagupta, S.P.; Mukherji, S. Strain specificity in antimicrobial activity of silver and copper
nanoparticles. Acta Biomater. 2008,4, 707–716. [CrossRef]
15.
Yoon, K.Y.; Byeon, J.H.; Park, J.H.; Hwang, J. Susceptibility constants of Escherichia coli and Bacillus subtilis to silver and copper
nanoparticles. Sci. Total Environ. 2007,373, 572–575. [CrossRef] [PubMed]
Nanomaterials 2022,12, 805 10 of 15
16.
Renne, W.G.; Lindner, A.; Mennito, A.S.; Agee, K.A.; Pashley, D.H.; Willett, D.; Sentelle, D.; Defee, M.; Schmidt, M.; Sabatini,
C. Antibacterial properties of copper iodide-doped glass ionomer-based materials and effect of copper iodide nanoparticles on
collagen degradation. Clin. Oral Investig. 2017,21, 369–379. [CrossRef] [PubMed]
17.
ALGhanem, A.; Fernandes, G.; Visser, M.; Dziak, R.; Renné, W.G.; Sabatini, C. Biocompatibility and Bond Degradation of
Poly-Acrylic Acid Coated Copper Iodide-Adhesives. Dent. Mater. 2017,33, e336–e347. [CrossRef]
18.
Argueta-Figueroa, L.; Scougall-Vilchis, R.J.; Morales-Luckie, R.A.; Olea-Mejia, O.F. An evaluation of the antibacterial properties
and shear bond strength of copper nanoparticles as a nanofiller in orthodontic adhesive. Aust. Orthod. J.
2015
,31, 42–48.
[CrossRef]
19.
Gosau, M.; Haupt, M.; Thude, S.; Strowitzki, M.; Schminke, B.; Buergers, R. Antimicrobial effect and biocompatibility of novel
metallic nanocrystalline implant coatings: Novel antibacterial implant surfaces. J. Biomed. Mater. Res. B Appl. Biomater.
2016
,
104, 1571–1579. [CrossRef] [PubMed]
20.
Zhang, Y.; Fu, S.; Yang, L.; Qin, G.; Zhang, E. A Nano-Structured TiO2/CuO/Cu2O Coating on Ti-Cu Alloy with Dual Function
of Antibacterial Ability and Osteogenic Activity. J. Mater. Sci. Technol. 2022,97, 201–212. [CrossRef]
21.
Vincent, M.; Duval, R.E.; Hartemann, P.; Engels-Deutsch, M. Contact killing and antimicrobial properties of copper. J. Appl.
Microbiol. 2018,124, 1032–1046. [CrossRef] [PubMed]
22.
Milanino, R. Copper in Medicine and Personal Care: A Historical Overview. In Copper and the Skin; Clinical & Basic Science Series;
Informa Healthcare: New York, NY, USA, 2006.
23.
Jin, S.; Ren, L.; Yang, K. Bio-functional Cu containing biomaterials: A New Way to enhance bio-adaption of biomaterials. J. Mater.
Sci. Technol. 2016,32, 835–839. [CrossRef]
24.
Jiang, W.; Mashayekhi, H.; Xing, B. Bacterial toxicity comparison between nano- and micro-scaled oxide particles. Environ. Pollut.
2009,157, 1619–1625. [CrossRef]
25.
Azam, A.; Ahmed, A.S.; Oves, M.; Khan, M.; Memic, A. Size-dependent antimicrobial properties of CuO nanoparticles against
Gram-positive and negative bacterial strains. Int. J. Nanomed. 2012,7, 3527–3535. [CrossRef]
26.
Amro, N.A.; Kotra, L.P.; Wadu-Mesthrige, K.; Bulychev, A.; Mobashery, S.; Liu, G.-Y. High-resolution atomic force microscopy
studies of the Escherichia coli outer membrane: Structural basis for permeability. Langmuir 2000,16, 2789–2796. [CrossRef]
27.
Tran, N.; Mir, A.; Mallik, D.; Sinha, A.; Nayar, S.; Webster, T.J. Bactericidal effect of iron oxide nanoparticles on Staphylococcus
aureus.Int. J. Nanomed. 2010,5, 277–283.
28.
Applerot, G.; Lellouche, J.; Lipovsky, A.; Nitzan, Y.; Lubart, R.; Gedanken, A.; Banin, E. Understanding the antibacterial
mechanism of CuO nanoparticles: Revealing the route of induced oxidative stress. Small 2012,8, 3326–3337. [CrossRef]
29.
Fang, J.; Lyon, D.Y.; Wiesner, M.R.; Dong, J.; Alvarez, P.J.J. Effect of a fullerene water suspension on bacterial phospholipids and
membrane phase behavior. Environ. Sci. Technol. 2007,41, 2636–2642. [CrossRef] [PubMed]
30.
Reddy, K.M.; Feris, K.; Bell, J.; Wingett, D.G.; Hanley, C.; Punnoose, A. Selective toxicity of zinc oxide nanoparticles to prokaryotic
and eukaryotic systems. Appl. Phys. Lett. 2007,90, 2139021–2139023. [CrossRef]
31.
Kim, J.S.; Kuk, E.; Yu, K.N.; Kim, J.-H.; Park, S.J.; Lee, H.J.; Kim, S.H.; Park, Y.K.; Park, Y.H.; Hwang, C.-Y.; et al. Antimicrobial
effects of silver nanoparticles. Nanomedicine 2007,3, 95–101. [CrossRef] [PubMed]
32.
Morones, J.R.; Elechiguerra, J.L.; Camacho, A.; Holt, K.; Kouri, J.B.; Ramírez, J.T.; Yacaman, M.J. The bactericidal effect of silver
nanoparticles. Nanotechnology 2005,16, 2346–2353. [CrossRef] [PubMed]
33.
Lok, C.-N.; Ho, C.-M.; Chen, R.; He, Q.-Y.; Yu, W.-Y.; Sun, H.; Tam, P.K.-H.; Chiu, J.-F.; Che, C.-M. Proteomic analysis of the mode
of antibacterial action of silver nanoparticles. J. Proteome Res. 2006,5, 916–924. [CrossRef]
34.
Sondi, I.; Salopek-Sondi, B. Silver nanoparticles as antimicrobial agent: A case study on E. coli as a model for Gram-negative
bacteria. J. Colloid Interface Sci. 2004,275, 177–182. [CrossRef] [PubMed]
35.
Raffi, M.; Mehrwan, S.; Bhatti, T.M.; Akhter, J.I.; Hameed, A.; Yawar, W.; ul Hasan, M.M. Investigations into the antibacterial
behavior of copper nanoparticles against Escherichia coli.Ann. Microbiol. 2010,60, 75–80. [CrossRef]
36.
Ren, G.; Hu, D.; Cheng, E.W.C.; Vargas-Reus, M.A.; Reip, P.; Allaker, R.P. Characterisation of Copper Oxide Nanoparticles for
Antimicrobial Applications. Int. J. Antimicrob. Agents 2009,33, 587–590. [CrossRef]
37.
Tee, J.K.; Ong, C.N.; Bay, B.H.; Ho, H.K.; Leong, D.T. Oxidative stress by inorganic nanoparticles. Wiley Interdiscip. Rev. Nanomed.
Nanobiotechnol. 2016,8, 414–438. [CrossRef]
38.
Cai, X.; Zhang, B.; Liang, Y.; Zhang, J.; Yan, Y.; Chen, X.; Wu, Z.; Liu, H.; Wen, S.; Tan, S.; et al. Study on the antibacterial
mechanism of copper ion- and neodymium ion-modified
α
-zirconium phosphate with better antibacterial activity and lower
cytotoxicity. Colloids Surf. B Biointerfaces 2015,132, 281–289. [CrossRef] [PubMed]
39. Borkow, G. Using copper to fight microorganisms. Curr. Chem. Biol. 2012,6, 93–103. [CrossRef]
40.
Wu, X.; Ye, L.; Liu, K.; Wang, W.; Wei, J.; Chen, F.; Liu, C. Antibacterial properties of mesoporous copper-doped silica xerogels.
Biomed. Mater. 2009,4, 045008. [CrossRef]
41.
Warnes, S.L.; Summersgill, E.N.; Keevil, C.W. Inactivation of murine norovirus on a range of copper alloy surfaces is accompanied
by loss of capsid integrity. Appl. Environ. Microbiol. 2015,81, 1085–1091. [CrossRef] [PubMed]
42.
Bleichert, P.; Espírito Santo, C.; Hanczaruk, M.; Meyer, H.; Grass, G. Inactivation of bacterial and viral biothreat agents on metallic
copper surfaces. Biometals 2014,27, 1179–1189. [CrossRef] [PubMed]
Nanomaterials 2022,12, 805 11 of 15
43.
Li, Y.; Pi, Q.M.; You, H.H.; Li, J.Q.; Wang, P.C.; Yang, X.; Wu, Y. A Smart Multi-Functional Coating Based on Anti-Pathogen
Micelles Tethered with Copper Nanoparticles via a Biosynthesis Method Using L-Vitamin C. RSC Adv.
2018
,8, 18272–18283.
[CrossRef]
44.
Sagripanti, J.L.; Routson, L.B.; Lytle, C.D. Virus inactivation by copper or iron ions alone and in the presence of peroxide. Appl.
Environ. Microbiol. 1993,59, 4374–4376. [CrossRef] [PubMed]
45.
Grass, G.; Rensing, C.; Solioz, M. Metallic copper as an antimicrobial surface. Appl. Environ. Microbiol.
2011
,77, 1541–1547.
[CrossRef] [PubMed]
46.
Bengtsson, U.G.; Hylander, L.D. Increased mercury emissions from modern dental amalgams. Biometals
2017
,30, 277–283.
[CrossRef] [PubMed]
47.
Al Sarraj, Z.S.A.; Atiyah, R.I. Preparation and characterization of high-copper restorative dental alloys corrected. Adv. Mater. Res.
2011,324, 69–72. [CrossRef]
48. Berry, T.G.; Osborne, J.S.; Summitt, J.B. Clinical evaluation of high-copper amalgams. Am. J. Dent. 1995,8, 122–124. [PubMed]
49.
Hasheminezhad, A.; Zebarjad, S.M.; Sajjadi, S.A.; Rahanjam, L. Effect of copper content on compressive strength and microstruc-
ture of dental amalgams. Engineering 2012,4, 155–159. [CrossRef]
50.
Sun, D.; Xu, D.; Yang, C.; Shahzad, M.B.; Sun, Z.; Xia, J.; Zhao, J.; Gu, T.; Yang, K.; Wang, G. An investigation of the antibacterial
ability and cytotoxicity of a novel cu-bearing 317L stainless steel. Sci. Rep. 2016,6, 29244. [CrossRef]
51.
Guan, J.; Guo, L.; Fu, Y.; Chai, H.
In vitro
evaluation of antibacterial activity and cytocompatibility of antibacterial stainless steel
containing copper. J. Biomed. Eng. 2013,30, 333–337.
52.
Chai, H.; Guo, L.; Wang, X.; Fu, Y.; Guan, J.; Tan, L.; Ren, L.; Yang, K. Antibacterial effect of 317L stainless steel contained copper
in prevention of implant-related infection in vitro and in vivo. J. Mater. Sci. Mater. Med. 2011,22, 2525–2535. [CrossRef]
53.
Liu, R.; Tang, Y.; Liu, H.; Zeng, L.; Ma, Z.; Li, J.; Zhao, Y.; Ren, L.; Yang, K. Effects of combined chemical design (Cu addition) and
topographical modification (SLA) of Ti-Cu/SLA for promoting osteogenic, angiogenic and antibacterial activities. J. Mater. Sci.
Technol. 2020,47, 202–215. [CrossRef]
54.
Zhuang, Y.; Zhang, S.; Yang, K.; Ren, L.; Dai, K. Antibacterial activity of copper-bearing 316L stainless steel for the prevention of
implant-related infection. J. Biomed. Mater. Res. B Appl. Biomater. 2020,108, 484–495. [CrossRef] [PubMed]
55.
Zhang, D.; Ren, L.; Zhang, Y.; Xue, N.; Yang, K.; Zhong, M. Antibacterial activity against Porphyromonas gingivalis and biological
characteristics of antibacterial stainless steel. Colloids Surf. B Biointerfaces 2013,105, 51–57. [CrossRef]
56.
Li, M.; Nan, L.; Liang, C.; Sun, Z.; Yang, L.; Yang, K. Antibacterial behavior and related mechanisms of martensitic Cu-bearing
stainless steel evaluated by a mixed infection model of Escherichia coli and Staphylococcus aureus
in vitro
.J. Mater. Sci. Technol.
2021,62, 139–147. [CrossRef]
57.
Yan, X.; Wan, P.; Tan, L.; Zhao, M.; Qin, L.; Yang, K. Corrosion and biological performance of biodegradable magnesium alloys
mediated by low copper addition and processing. Mater. Sci. Eng. C Mater. Biol. Appl. 2018,93, 565–581. [CrossRef] [PubMed]
58.
Liu, C.; Fu, X.; Pan, H.; Wan, P.; Wang, L.; Tan, L.; Wang, K.; Zhao, Y.; Yang, K.; Chu, P.K. Biodegradable Mg-Cu alloys with
enhanced osteogenesis, angiogenesis, and long-lasting antibacterial effects. Sci. Rep. 2016,6, 27374. [CrossRef] [PubMed]
59.
Ma, Z.; Li, M.; Liu, R.; Ren, L.; Zhang, Y.; Pan, H.; Zhao, Y.; Yang, K.
In vitro
study on an antibacterial Ti-5Cu alloy for medical
application. J. Mater. Sci. Mater. Med. 2016,27, 91. [CrossRef]
60.
Bai, B.; Zhang, E.; Liu, J.; Zhu, J. The anti-bacterial activity of titanium-copper sintered alloy against Porphyromonas gingivalis
in vitro. Dent. Mater. J. 2016,35, 659–667. [CrossRef]
61.
Guo, S.; Lu, Y.; Wu, S.; Liu, L.; He, M.; Zhao, C.; Gan, Y.; Lin, J.; Luo, J.; Xu, X.; et al. Preliminary study on the corrosion resistance,
antibacterial activity and cytotoxicity of selective-laser-melted Ti
6
Al
4
V-xCu alloys. Mater. Sci. Eng. C Mater. Biol. Appl.
2017
,
72, 631–640. [CrossRef]
62.
Li, M.; Ma, Z.; Zhu, Y.; Xia, H.; Yao, M.; Chu, X.; Wang, X.; Yang, K.; Yang, M.; Zhang, Y.; et al. Toward a molecular understanding
of the antibacterial mechanism of copper-bearing titanium alloys against Staphylococcus aureus.Adv. Healthc. Mater.
2016
,
5, 557–566. [CrossRef]
63.
Liu, R.; Memarzadeh, K.; Chang, B.; Zhang, Y.; Ma, Z.; Allaker, R.P.; Ren, L.; Yang, K. Antibacterial effect of copper-bearing
titanium alloy (Ti-Cu) against Streptococcus mutans and Porphyromonas gingivalis.Sci. Rep. 2016,6, 29985. [CrossRef] [PubMed]
64.
Wu, C.; Zhou, Y.; Xu, M.; Han, P.; Chen, L.; Chang, J.; Xiao, Y. Copper-containing mesoporous bioactive glass scaffolds with
multifunctional properties of angiogenesis capacity, osteostimulation and antibacterial activity. Biomaterials
2013
,34, 422–433.
[CrossRef] [PubMed]
65.
Bari, A.; Bloise, N.; Fiorilli, S.; Novajra, G.; Vallet-Regí, M.; Bruni, G.; Torres-Pardo, A.; González-Calbet, J.M.; Visai, L.; Vitale-
Brovarone, C. Copper-containing mesoporous bioactive glass nanoparticles as multifunctional agent for bone regeneration. Acta
Biomater. 2017,55, 493–504. [CrossRef] [PubMed]
66.
Koohkan, R.; Hooshmand, T.; Tahriri, M.; Mohebbi-Kalhori, D. Synthesis, characterization and
in vitro
bioactivity of mesoporous
copper silicate bioactive glasses. Ceram. Int. 2018,44, 2390–2399. [CrossRef]
67.
Fowler, L.; Masia, N.; Cornish, L.A.; Chown, L.H.; Engqvist, H.; Norgren, S.; Öhman-Mägi, C. Development of antibacterial
Ti-Cu(x) alloys for dental applications: Effects of ageing for alloys with up to 10 wt% Cu. Materials 2019,12, 4017. [CrossRef]
68.
Rosenbaum, J.; Versace, D.L.; Abbad-Andallousi, S.; Pires, R.; Azevedo, C.; Cénédese, P.; Dubot, P. Antibacterial properties of
nanostructured Cu-TiO2surfaces for dental implants. Biomater. Sci. 2017,5, 455–462. [CrossRef]
Nanomaterials 2022,12, 805 12 of 15
69.
Astasov-Frauenhoffer, M.; Koegel, S.; Waltimo, T.; Zimmermann, A.; Walker, C.; Hauser-Gerspach, I.; Jung, C. Antimicrobial
efficacy of copper-doped titanium surfaces for dental implants. J. Mater. Sci. Mater. Med. 2019,30, 84. [CrossRef]
70.
Morales, A.G.; Jofre, J.; Perez-Tijerina, E.; Sólis-Pomar, S.; Sánchez-Sanhueza, G.; Mf, M. Effect of titanium coated with 3 different
types of copper nanoparticles in the oral biofilm formation. J. Dent. Health Oral Disord. Ther. 2021,12, 1–6.
71.
Liu, H.; Tang, Y.; Zhang, S.; Liu, H.; Wang, Z.; Li, Y.; Wang, X.; Ren, L.; Yang, K.; Qin, L. Anti-infection mechanism of a novel
dental implant made of titanium-copper (TiCu) alloy and its mechanism associated with oral microbiology. Bioact. Mater.
2022
,
8, 381–395. [CrossRef]
72.
Hameed, H.A. Evaluation of Antibacterial Properties of Copper Nanoparticles Surface Coating on Titanium Dental Implant. J.
Pharm. Sci. Res 2018,10, 1157–1160.
73.
Gil, F.J.; Planell, J.A. Effect of copper addition on the superelastic behavior of Ni-Ti shape memory alloys for orthodontic
applications. J. Biomed. Mater. Res. 1999,48, 682–688. [CrossRef]
74.
Sachdeva, R.C.L.; Miyazaki, S.; Farzin-Nia, F. Orthodontic Archwire and Method of Moving Teeth. U.S. Patent Application No.
5,044,947, 3 September 1991.
75.
Darabara, M.S.; Bourithis, L.I.; Zinelis, S.; Papadimitriou, G.D. Metallurgical characterization, galvanic corrosion, and ionic release
of orthodontic brackets coupled with Ni-Ti archwires. J. Biomed. Mater. Res. B Appl. Biomater. 2007,81B, 126–134. [CrossRef]
76.
Pompei-Reynolds, R.C.; Kanavakis, G. Interlot variations of transition temperature range and force delivery in copper-nickel-
titanium orthodontic wires. Am. J. Orthod. Dentofacial Orthop. 2014,146, 215–226. [CrossRef] [PubMed]
77.
Kusy, R.P.; Whitley, J.Q. Thermal and mechanical characteristics of stainless steel, titanium-molybdenum, and nickel-titanium
archwires. Am. J. Orthod. Dentofacial Orthop. 2007,131, 229–237. [CrossRef] [PubMed]
78.
Phukaoluan, A.; Khantachawana, A.; Kaewtatip, P.; Dechkunakorn, S.; Anuwongnukroh, N.; Santiwong, P.; Kajornchaiyakul, J.
Comparison of friction forces between stainless orthodontic steel brackets and TiNi wires in wet and dry conditions. Int. Orthod.
2017,15, 13–24. [CrossRef] [PubMed]
79.
Pandis, N.; Polychronopoulou, A.; Eliades, T. Alleviation of mandibular anterior crowding with copper-nickel-titanium vs.
nickel-titanium wires: A double-blind randomized control trial. Am. J. Orthod. Dentofac. Orthop.
2009
,136, 152.e1–152.e7.
[CrossRef]
80.
Shoeib, A.; Shaker, M.; Abdeen, R.; El-Segai, A. Evaluation of silver and copper oxide NANOPARTICLES release from different
prosthetic materials incorporated with nanoparticles. Egypt. Dent. J. 2019,65, 2849–2855. [CrossRef]
81.
Marovic, D.; Haugen, H.J.; Negovetic Mandic, V.; Par, M.; Zheng, K.; Tarle, Z.; Boccaccini, A.R. Incorporation of copper-doped
mesoporous bioactive glass nanospheres in experimental dental composites: Chemical and mechanical characterization. Materials
2021,14, 2611. [CrossRef]
82.
Gutiérrez, M.F.; Malaquias, P.; Hass, V.; Matos, T.P.; Lourenço, L.; Reis, A.; Loguercio, A.D.; Farago, P.V. The role of copper
nanoparticles in an etch-and-rinse adhesive on antimicrobial activity, mechanical properties and the durability of resin-dentine
interfaces. J. Dent. 2017,61, 12–20. [CrossRef]
83.
Sabatini, C.; Mennito, A.S.; Wolf, B.J.; Pashley, D.H.; Renné, W.G. Incorporation of bactericidal poly-acrylic acid modified copper
iodide particles into adhesive resins. J. Dent. 2015,43, 546–555. [CrossRef]
84.
Foley, J.; Evans, D.J.; Lloyd, C.H.; Blackwell, A. Black copper phosphate cement: Does it have a future? Eur. J. Prosthodont. Restor.
Dent. 2001,9, 67–71. [PubMed]
85.
Foley, J.; Blackwell, A. Ion Release from Copper Phosphate Cement and Influence on Streptococcus mutans Growth
in vitro
: A
Comparative Study. Caries Res. 2003,37, 416–424. [CrossRef] [PubMed]
86.
Foley, J.; Evans, D.J.; Blackwell, A. Restoration of primary teeth: A study of copper phosphate cement. Health Bull.
2001
,59, 45–48.
87.
Song, H.B.; Wang, X.; Patton, J.R.; Stansbury, J.W.; Bowman, C.N. Kinetics and mechanics of photo-polymerized triazole-
containing thermosetting composites via the copper(I)-catalyzed azide-alkyne cycloaddition. Dent. Mater.
2017
,33, 621–629.
[CrossRef]
88.
Aguilar-Perez, D.; Vargas-Coronado, R.; Cervantes-Uc, J.M.; Rodriguez-Fuentes, N.; Aparicio, C.; Covarrubias, C.; Alvarez-Perez,
M.; Garcia-Perez, V.; Martinez-Hernandez, M.; Cauich-Rodriguez, J.V. Antibacterial activity of a glass ionomer cement doped
with copper nanoparticles. Dent. Mater. J. 2020,39, 389–396. [CrossRef]
89.
Rau, J.V.; Wu, V.M.; Graziani, V.; Fadeeva, I.V.; Fomin, A.S.; Fosca, M.; Uskokovi´c, V. The Bone Building Blues: Self-hardening
copper-doped calcium phosphate cement and its
in vitro
assessment against mammalian cells and bacteria. Mater. Sci. Eng. C
Mater. Biol. Appl. 2017,79, 270–279. [CrossRef]
90.
Lin, Z.; Cao, Y.; Zou, J.; Zhu, F.; Gao, Y.; Zheng, X.; Wang, H.; Zhang, T.; Wu, T. Improved osteogenesis and angiogenesis of a
novel copper ions doped calcium phosphate cement. Mater. Sci. Eng. C Mater. Biol. Appl. 2020,114, 111032. [CrossRef]
91.
Zhang, J.; Wu, H.; He, F.; Wu, T.; Zhou, L.; Ye, J. Concentration-dependent osteogenic and angiogenic biological performances of
calcium phosphate cement modified with copper ions. Mater. Sci. Eng. C Mater. Biol. Appl. 2019,99, 1199–1212. [CrossRef]
92.
Wassmann, T.; Schubert, A.; Malinski, F.; Rosentritt, M.; Krohn, S.; Techmer, K.; Bürgers, R. The antimicrobial and cytotoxic effects
of a copper-loaded zinc oxide phosphate cement. Clin. Oral Investig. 2020,24, 3899–3909. [CrossRef]
93.
Thomas, B.; Gautam, A.; Prasad, B.R.; Kumari, S. Evaluation of micronutrient (zinc, copper, and iron) levels in periodontitis
patients with and without diabetes mellitus type 2: A biochemical study. Indian J. Dent. Res. 2013,24, 468–473.
94.
Thomas, B.; Ramesh, A.; Suresh, S.; Prasad, B.R. A comparative evaluation of antioxidant enzymes and selenium in the serum of
periodontitis patients with diabetes mellitus type 2. Contemp. Clin. Dent. 2013,4, 176–180.
Nanomaterials 2022,12, 805 13 of 15
95.
Sundaram, G.; Ramakrishnan, T.; Parthasarathy, H.; Moses, J.; Lalitha, T. Evaluation of micronutrient (zinc, magnesium, and
copper) levels in serum and glycemic status after nonsurgical periodontal therapy in type 2 diabetic patients with chronic
periodontitis. Contemp. Clin. Dent. 2017,8, 26–32. [CrossRef] [PubMed]
96.
Dannan, A.; Hanno, Y. The relationship between periodontal diseases and plasma level of copper and magnesium. Dentistry
2018
,
8, 1000471. [CrossRef]
97.
Herman, M.; Golasik, M.; Piekoszewski, W.; Walas, S.; Napierala, M.; Wyganowska-Swiatkowska, M.; Kurhanska-Flisykowska,
A.; Wozniak, A.; Florek, E. Essential and toxic metals in oral fluid-a potential role in the diagnosis of periodontal diseases. Biol.
Trace Elem. Res. 2016,173, 275–282. [CrossRef] [PubMed]
98.
Martin, R.R.; Naftel, S.J.; Nelson, A.J.; Edwards, M.; Mithoowani, H.; Stakiw, J. Synchrotron radiation analysis of possible
correlations between metal status in human cementum and periodontal disease. J. Synchrotron Radiat.
2010
,17, 263–267.
[CrossRef]
99.
Manea, A.; Nechifor, M. Research on plasma and saliva levels of some bivalent cations in patients with chronic periodontitis
(salivary cations in chronic periodontitis). Rev. Med. Chir. Soc. Med. Nat. Iasi 2014,118, 439–449. [PubMed]
100.
González, J.P.; Covarrubias, C.; Cádiz, M.; Corral, C.; Cuadra, F.; Fuentevilla, I. Design of Antimicrobial Release Systems Based on
Chitosan and Copper Nanoparticles for Localized Periodontal Therapy. J. Dent. Oral Disord. 2016,2, 1035.
101.
Majbauddin, A.; Kodani, I.; Ryoke, K. The effect of bamboo leaf extract solution and sodium copper chlorophyllin solution on
growth and volatile sulfur compounds production of oral malodor associated some anaerobic periodontal bacteria. Yonago Acta
Med. 2015,58, 129–136.
102.
Meto, A.; Droboniku, E.; Blasi, E.; Colombari, B.; Tragaj, E.; Cervino, G.; Fiorillo, L.; Meto, A. Copper–calcium hydroxide and
permanent electrophoretic current for treatment of apical periodontitis. Materials 2021,14, 678. [CrossRef]
103.
Gould, S.W.J.; Fielder, M.D.; Kelly, A.F.; Morgan, M.; Kenny, J.; Naughton, D.P. The antimicrobial properties of copper surfaces
against a range of important nosocomial pathogens. Ann. Microbiol. 2009,59, 151–156. [CrossRef]
104.
Sierra, M.; Sanhueza, A.; Alcántara, R.; Sánchez, G. Antimicrobial Evaluation of Copper Sulfate (II) on Strains of Enterococcus
Faecalis. In Vitro Study. J. Oral Res. 2013,2, 114–118. [CrossRef]
105.
Sánchez-Sanhueza, G.; Rebolledo, S.; López, J.; Encalada, M.; Bello-Toledo, H.; Rojas, D.; Medinam, C.; Melendrez, M.F. Synthesis
of copper nanowires and their antimicrobial activity on strains isolated persistent endodontic infections. J. Nanosci. Nanotechnol.
2018,18, 4507–4514. [CrossRef]
106.
Sánchez-Sanhueza, G.; Alcántara-Dufeu, R.; Carrillo, L.; Mansilla, H.; Novoa, C.; Bello-Toledo, H. Ex vivo Effect of Copper Sulfate
on Enterococcus faecalis in Root Canals. Int. J. Odontostomatol. 2015,9, 505–510. [CrossRef]
107.
Meto, A.; Colombari, B.; Sala, A.; Pericolini, E.; Meto, A.; Peppoloni, S.; Blasi, E. Antimicrobial and antibiofilm efficacy of a
copper/calcium hydroxide-based endodontic paste against Staphylococcus aureus,Pseudomonas aeruginosa and Candida albicans.
Dent. Mater. J. 2019,38, 591–603. [CrossRef]
108.
Zhang, F.; Zhou, M.; Gu, W.; Shen, Z.; Ma, X.; Lu, F.; Yang, X.; Zheng, Y.; Gou, Z. Zinc-/copper-substituted dicalcium silicate
cement: Advanced biomaterials with enhanced osteogenesis and long-term antibacterial properties. J. Mater. Chem. B Mater. Biol.
Med. 2020,8, 1060–1070. [CrossRef] [PubMed]
109.
Jacobs, A.; Renaudin, G.; Charbonnel, N.; Nedelec, J.-M.; Forestier, C.; Descamps, S. Copper-doped Biphasic Calcium Phosphate
powders: Dopant release, cytotoxicity and antibacterial properties. Materials 2021,14, 2393. [CrossRef] [PubMed]
110.
Gomes, S.; Vichery, C.; Descamps, S.; Martinez, H.; Kaur, A.; Jacobs, A.; Nedelec, J.-M.; Renaudin, G. Cu-doping of calcium
phosphate bioceramics: From mechanism to the control of cytotoxicity. Acta Biomater. 2018,65, 462–474. [CrossRef]
111.
Zhang, W.; Chang, Q.; Xu, L.; Li, G.; Yang, G.; Ding, X.; Wang, X.; Cui, D.; Jiang, X. Graphene oxide-copper nanocomposite-coated
porous CaP scaffold for vascularized bone regeneration via activation of hif-1
α
.Adv. Healthc. Mater.
2016
,5, 1299–1309. [CrossRef]
112.
Costerton, J.W.; Stewart, P.S.; Greenberg, E.P. Bacterial biofilms: A common cause of persistent infections. Science
1999
,
284, 1318–1322. [CrossRef] [PubMed]
113.
Sun, D.; Xu, D.; Yang, C.; Chen, J.; Shahzad, M.B.; Sun, Z.; Zhao, J.; Gu, T.; Yang, K.; Wang, G. Inhibition of Staphylococcus aureus
biofilm by a copper-bearing 317L-Cu stainless steel and its corrosion resistance. Mater. Sci. Eng. C Mater. Biol. Appl.
2016
,
69, 744–750. [CrossRef]
114.
Chen, A.F.; Parvizi, J. Antibiotic-loaded bone cement, and periprosthetic joint infection. J. Long Term Eff. Med. Implant.
2014
,
24, 89–97. [CrossRef] [PubMed]
115.
Han, J.; Yang, Y.; Lu, J.; Wang, C.; Xie, Y.; Zheng, X.; Yao, Z.; Zhang, C. Sustained release vancomycin-coated titanium alloy using
a novel electrostatic dry powder coating technique may be a potential strategy to reduce implant-related infection. Biosci. Trends
2017,11, 346–354. [CrossRef]
116.
Liu, J.; Zhang, D.; Pan, X.; Wang, L. Characterization of the complexation between Al
3+
and extracellular polymeric substances
prepared from alga-bacteria biofilm. Chin. J. Appl. Environ. Biol 2009,15, 347–350.
117.
Zhao, W.; Walker, S.L.; Huang, Q.; Cai, P. Contrasting effects of extracellular polymeric substances on the surface characteristics
of bacterial pathogens and cell attachment to soil particles. Chem. Geol. 2015,410, 79–88. [CrossRef]
118.
Xia, C.; Ma, X.; Zhang, X.; Li, K.; Tan, J.; Qiao, Y.; Liu, X. Enhanced physicochemical and biological properties of C/Cu dual ions
implanted medical titanium. Bioact. Mater. 2020,5, 377–386. [CrossRef] [PubMed]
119.
Xu, W.; Hou, C.; Mao, Y.; Yang, L.; Tamaddon, M.; Zhang, J.; Qu, X.; Liu, C.; Su, B.; Lu, X. Characteristics of novel Ti-10Mo-xCu
alloy by powder metallurgy for potential biomedical implant applications. Bioact. Mater.
2020
,5, 659–666. [CrossRef] [PubMed]
Nanomaterials 2022,12, 805 14 of 15
120.
Ahmed, S.; Hadeel, S.; Ahmed, M. Evaluation of anti-fungal effect of nano-particles within different types of acrylic resin denture
bases. Egypt. Dent. J. 2015,61, 3443–3449.
121.
Torres-Rosas, R.; Torres-Gómez, N.; García-Contreras, R.; Scougall-Vilchis, R.; Domínguez-Díaz, L.; Argueta-Figueroa, L. Copper
nanoparticles as nanofillers in an adhesive resin system: An in vitro study. Dent. Med. Probl. 2020,57, 239–246. [CrossRef]
122.
Nourollahi, M.; Meryon, S.D. The antibacterial properties of four elements released from dental restorative materials. Int. Endod.
J. 1989,22, 9–16. [CrossRef]
123.
Grossman, E.S.; Dip, H.; Witcomb, M.J.; Matejka, J.M. Influence of amalgams, bases, and varnish on seal composition at restoration
tooth interfaces. J. Prosthet. Dent. 1995,73, 290–298. [CrossRef]
124.
Dionysopoulos, P.; Kotsanos, N.; Koliniotou-Koubia, E.; Papagodiannis, Y. Secondary caries formation
in vitro
around fluoride-
releasing restorations. Oper. Dent. 1994,19, 183–188.
125.
Habibovic, P.; Barralet, J.E. Bioinorganics and biomaterials: Bone repair. Acta Biomater.
2011
,7, 3013–3026. [CrossRef] [PubMed]
126.
Willis, M.S.; Monaghan, S.A.; Miller, M.L.; McKenna, R.W.; Perkins, W.D.; Levinson, B.S.; Bhushan, V.; Kroft, S.H. Zinc-induced
copper deficiency: A report of three cases initially recognized on bone marrow examination: A report of three cases initially
recognized on bone marrow examination. Am. J. Clin. Pathol. 2005,123, 125–131. [CrossRef] [PubMed]
127.
Ran, S.; Wang, J.; Jiang, W.; Zhu, C.; Liang, J. Assessment of dentinal tubule invasion capacity of Enterococcus faecalis under stress
conditions ex vivo. Int. Endod. J. 2015,48, 362–372. [CrossRef]
128.
Hohscheidt, G.L.; Böttcher, D.E.; Fatturi Parolo, C.C.; Montagner, F.; Grecca, F.S. Response of E. faecalis biofilms to different
associations of auxiliary substances during root canal preparation: A confocal laser microscopy analysis: Irrigation protocols
during endodontics. Microsc. Res. Tech. 2013,76, 658–662. [CrossRef] [PubMed]
129.
Colvin, V.L. The potential environmental impact of engineered nanomaterials. Nat. Biotechnol.
2003
,21, 1166–1170. [CrossRef]
[PubMed]
130.
Georgopoulos, P.G.; Roy, A.; Yonone-Lioy, M.J.; Opiekun, R.E.; Lioy, P.J. Environmental copper: Its dynamics and human exposure
issues. J. Toxicol. Environ. Health B Crit. Rev. 2001,4, 341–394. [CrossRef]
131.
Fahmy, B.; Cormier, S.A. Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells. Toxicol.
Vitr. 2009,23, 1365–1371. [CrossRef]
132.
Cho, W.-S.; Duffin, R.; Poland, C.A.; Duschl, A.; Oostingh, G.J.; Macnee, W.; Bradley, M.; Megson, I.L.; Donaldson, K. Differential
pro-inflammatory effects of metal oxide nanoparticles and their soluble ions
in vitro
and
in vivo
; zinc and copper nanoparticles,
but not their ions, recruit eosinophils to the lungs. Nanotoxicology 2012,6, 22–35. [CrossRef]
133.
Rodhe, Y.; Skoglund, S.; Odnevall Wallinder, I.; Potácová, Z.; Möller, L. Copper-based nanoparticles induce high toxicity in
leukemic HL60 cells. Toxicol. Vitr. 2015,29, 1711–1719. [CrossRef]
134.
Siddiqui, M.A.; Alhadlaq, H.A.; Ahmad, J.; Al-Khedhairy, A.A.; Musarrat, J.; Ahamed, M. Copper oxide nanoparticles induced
mitochondria mediated apoptosis in human hepatocarcinoma cells. PLoS ONE 2013,8, e69534. [CrossRef] [PubMed]
135. Kahru, A.; Savolainen, K. Potential hazard of nanoparticles: From properties to biological and environmental effects. Toxicology
2010,269, 89–91. [CrossRef] [PubMed]
136.
Prabhu, B.M.; Ali, S.F.; Murdock, R.C.; Hussain, S.M.; Srivatsan, M. Copper nanoparticles exert size and concentration dependent
toxicity on somatosensory neurons of rat. Nanotoxicology 2010,4, 150–160. [CrossRef]
137.
Xu, J.; Li, Z.; Xu, P.; Xiao, L.; Yang, Z. Nanosized copper oxide induces apoptosis through oxidative stress in podocytes. Arch.
Toxicol. 2013,87, 1067–1073. [CrossRef]
138.
Chen, Z.; Meng, H.; Xing, G.; Chen, C.; Zhao, Y.; Jia, G.; Wang, T.; Yuan, H.; Ye, C.; Zhao, F.; et al. Acute toxicological effects of
copper nanoparticles in vivo. Toxicol. Lett. 2006,163, 109–120. [CrossRef] [PubMed]
139.
Manna, P.; Ghosh, M.; Ghosh, J.; Das, J.; Sil, P.C. Contribution of nano-copper particles to
in vivo
liver dysfunction and cellular
damage: Role of IκBα/NF-κB, MAPKs and mitochondrial signal. Nanotoxicology 2012,6, 1–21. [CrossRef] [PubMed]
140.
Lei, R.; Wu, C.; Yang, B.; Ma, H.; Shi, C.; Wang, Q.; Wang, Q.; Yuan, Y.; Liao, M. Integrated metabolomic analysis of the nano-sized
copper particle-induced hepatotoxicity and nephrotoxicity in rats: A rapid
in vivo
screening method for nanotoxicity. Toxicol.
Appl. Pharmacol. 2008,232, 292–301. [CrossRef] [PubMed]
141.
Meng, H.; Chen, Z.; Xing, G.; Yuan, H.; Chen, C.; Zhao, F.; Zhang, C.; Zhao, Y. Ultrahigh reactivity provokes nanotoxicity:
Explanation of oral toxicity of nano-copper particles. Toxicol. Lett. 2007,175, 102–110. [CrossRef] [PubMed]
142.
Zietz, B.P.; Dieter, H.H.; Lakomek, M.; Schneider, H.; Kessler-Gaedtke, B.; Dunkelberg, H. Epidemiological investigation on
chronic copper toxicity to children exposed via the public drinking water supply. Sci. Total Environ.
2003
,302, 127–144. [CrossRef]
143.
Bertinato, J.; L’Abbé, M.R. Maintaining copper homeostasis: Regulation of copper-trafficking proteins in response to copper
deficiency or overload. J. Nutr. Biochem. 2004,15, 316–322. [CrossRef]
144.
Sarkar, A.; Das, J.; Manna, P.; Sil, P.C. Nano-copper induces oxidative stress and apoptosis in kidney via both extrinsic and
intrinsic pathways. Toxicology 2011,290, 208–217. [CrossRef] [PubMed]
145.
Chaves, S.B.; Lacava, L.M.; Lacava, Z.G.M.; Silva, O.; Pelegrini, F.; Buske, N.; Gansau, C.; Morais, P.C.; Azevedo, R.B. Light
microscopy and magnetic resonance characterization of a DMSA-coated magnetic fluid in mice. IEEE Trans. Magn.
2002
,
38, 3231–3233. [CrossRef]
146.
Nizami, M.Z.I.; Xu, V.W.; Yin, I.X.; Yu, O.Y.; Chu, C.-H. Metal and Metal Oxide Nanoparticles in Caries Prevention: A Review.
Nanomaterials 2021,11, 3446. [CrossRef] [PubMed]
Nanomaterials 2022,12, 805 15 of 15
147.
Sánchez-Sanhueza, G.; Fuentes-Rodríguez, D.; Bello-Toledo, H. Copper Nanoparticles as Potential Antimicrobial Agent in
Disinfecting Root Canals: A Systematic Review. Int. J. Odontostomatol. 2016,10, 547–554. [CrossRef]
148.
Allaker, R.P. The Use of Antimicrobial Nanoparticles to Control Oral Infections. In Nano-Antimicrobials; Springer:
Berlin/Heidelberg, Germany, 2012; pp. 395–425. ISBN 9783642244278.